Vetoquinol (VETO) - Total Assets
Based on the latest financial reports, Vetoquinol (VETO) holds total assets worth €725.82 Million EUR (≈ $848.56 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see VETO cash flow conversion for how efficiently the company converts equity into cash flow.
Vetoquinol - Total Assets Trend (2004–2024)
This chart illustrates how Vetoquinol's total assets have evolved over time, based on quarterly financial data. See VETO share price today for real-time trading data and today's change.
Vetoquinol - Asset Composition Analysis
Current Asset Composition (December 2024)
Vetoquinol's total assets of €725.82 Million consist of 56.6% current assets and 43.4% non-current assets. Explore Vetoquinol (VETO) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €1.00K | 27.7% |
| Accounts Receivable | €92.56 Million | 12.4% |
| Inventory | €112.29 Million | 15.1% |
| Property, Plant & Equipment | €92.60 Million | 12.4% |
| Intangible Assets | €142.09 Million | 19.1% |
| Goodwill | €76.41 Million | 10.3% |
Asset Composition Trend (2004–2024)
This chart illustrates how Vetoquinol's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vetoquinol's current assets represent 56.6% of total assets in 2024, an increase from 0.0% in 2004.
- Cash Position: Cash and equivalents constituted 27.7% of total assets in 2024, up from 7.7% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, a decrease from 31.0% in 2004.
- Asset Diversification: The largest asset category is intangible assets at 19.1% of total assets.
Vetoquinol Competitors by Total Assets
Key competitors of Vetoquinol based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262
|
China | CN¥9.54 Billion |
|
Neuland Laboratories Limited
NSE:NEULANDLAB
|
India | Rs29.30 Billion |
|
Shandong Buchang Pharmaceuticals Co Ltd
SHG:603858
|
China | CN¥19.57 Billion |
|
Hunan Warrant Pharmaceutical Co. Ltd. A
SHG:688799
|
China | CN¥2.53 Billion |
|
Bide Pharmatech Co. Ltd. A
SHG:688073
|
China | CN¥2.54 Billion |
|
Luye Pharma Group Ltd
F:LUP
|
Germany | €32.83 Billion |
|
Jiangsu Jibeier Pharmaceutical Co Ltd
SHG:688566
|
China | CN¥2.72 Billion |
|
Shanxi Zhendong Pharmaceutical
SHE:300158
|
China | CN¥4.51 Billion |
Vetoquinol - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.11 | 2.76 | 2.73 |
| Quick Ratio | 2.13 | 1.91 | 1.89 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €282.00 Million | €244.67 Million | €173.20 Million |
Vetoquinol - Advanced Valuation Insights
This section examines the relationship between Vetoquinol's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.83 |
| Latest Market Cap to Assets Ratio | 1.38 |
| Asset Growth Rate (YoY) | 7.5% |
| Total Assets | €744.13 Million |
| Market Capitalization | $1.02 Billion USD |
Valuation Analysis
Above Book Valuation: The market values Vetoquinol's assets above their book value (1.38x), reflecting positive investor sentiment about the company's future prospects.
Positive Asset Growth: Vetoquinol's assets grew by 7.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Vetoquinol (2004–2024)
The table below shows the annual total assets of Vetoquinol from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €744.13 Million ≈ $869.97 Million |
+7.50% |
| 2023-12-31 | €692.23 Million ≈ $809.29 Million |
+6.20% |
| 2022-12-31 | €651.85 Million ≈ $762.08 Million |
+4.37% |
| 2021-12-31 | €624.56 Million ≈ $730.18 Million |
-3.33% |
| 2020-12-31 | €646.09 Million ≈ $755.35 Million |
+26.32% |
| 2019-12-31 | €511.47 Million ≈ $597.96 Million |
+9.86% |
| 2018-12-31 | €465.58 Million ≈ $544.32 Million |
+4.87% |
| 2017-12-31 | €443.97 Million ≈ $519.05 Million |
+1.09% |
| 2016-12-31 | €439.17 Million ≈ $513.44 Million |
+6.47% |
| 2015-12-31 | €412.48 Million ≈ $482.23 Million |
-1.64% |
| 2014-12-31 | €419.36 Million ≈ $490.28 Million |
+19.19% |
| 2013-12-31 | €351.83 Million ≈ $411.33 Million |
-1.29% |
| 2012-12-31 | €356.44 Million ≈ $416.71 Million |
+11.98% |
| 2011-12-31 | €318.31 Million ≈ $372.14 Million |
+2.86% |
| 2010-12-31 | €309.45 Million ≈ $361.78 Million |
+9.09% |
| 2009-12-31 | €283.67 Million ≈ $331.64 Million |
+19.98% |
| 2008-12-31 | €236.43 Million ≈ $276.41 Million |
+3.51% |
| 2007-12-31 | €228.41 Million ≈ $267.03 Million |
+8.44% |
| 2006-12-31 | €210.62 Million ≈ $246.24 Million |
+5.46% |
| 2005-12-31 | €199.72 Million ≈ $233.49 Million |
+12.86% |
| 2004-12-31 | €176.96 Million ≈ $206.89 Million |
-- |
About Vetoquinol
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more